Integrin α vβ 3-targeted IRDye 800CW near-infrared imaging of glioblastoma Journal Article
| Authors: | Huang, R.; Vider, J.; Kovar, J. L.; Olive, D. M.; Mellinghoff, I. K.; Mayer-Kuckuk, P.; Kircher, M. F.; Blasberg, R. G. |
| Article Title: | Integrin α vβ 3-targeted IRDye 800CW near-infrared imaging of glioblastoma |
| Abstract: | Purpose: Integrin α vβ 3 plays an important role in tumor angiogenesis, growth, and metastasis. We have tested a targeted probe to visualize integrin receptor expression in glioblastomas using near-infrared fluorescent (NIRF) imaging. Experimental design: A transgenic glioblastoma mouse model (RCAS-PDGF-driven/tv-a glioblastoma, which mimics the infiltrative growth pattern of human glioblastomas) and two human orthotopic glioblastoma models (U-87MG with high integrin β 3 expression and TS543 with low integrin β 3 expression) were studied. An integrin-targeting NIRF probe, IRDye 800CW-cyclic-RGD peptide (IRDye 800CW-RGD), was tested by in vivo and ex vivo NIRF imaging. Results: We show that the IRDye 800CW-RGD peptide: (i) specifically binds to integrin receptors; (ii) is selectively localized to glioblastoma tissue with overexpressed integrin receptors and is retained over prolonged periods of time; (iii) is associated with minimal autofluorescence and photobleaching because of imaging at 800 nm; (iv) provides delineation of tumor tissue with high precision because of a high tumor-to-normal brain fluorescence ratio (79.7 ± 6.9, 31.2 ± 2.8, and 16.3 ± 1.3) in the U-87 MG, RCAS-PDGF, and TS543 models, respectively; P < 0.01); and (v) enables fluorescence-guided glioblastoma resection. Importantly, small foci of residual fluorescence were observed after resection was completed using white light imaging alone, and these fluorescent foci were shown to represent residual tumor tissue by histology. Conclusions: NIRF imaging with the IRDye 800CW-RGD probe provides a simple, rapid, low-cost, nonradioactive, and highly translatable approach for improved intraoperative glioblastoma visualization and resection. It also has the potential to serve as an imaging platform for noninvasive cancer detection and drug efficacy evaluation studies. ©2012 AACR. |
| Keywords: | controlled study; protein expression; nonhuman; validation process; binding affinity; mouse; animal tissue; fluorescent dye; bleaching; animal experiment; animal model; in vivo study; molecular imaging; transgenic mouse; glioblastoma; ex vivo study; molecular probe; fluorescence imaging; vitronectin receptor; autofluorescence; near infrared fluorescent imaging |
| Journal Title: | Clinical Cancer Research |
| Volume: | 18 |
| Issue: | 20 |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2012-10-15 |
| Start Page: | 5731 |
| End Page: | 5740 |
| Language: | English |
| DOI: | 10.1158/1078-0432.ccr-12-0374 |
| PROVIDER: | scopus |
| PUBMED: | 22914772 |
| PMCID: | PMC3733255 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 2 November 2012" - "CODEN: CCREF" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
269Mellinghoff -
272Blasberg -
30Huang -
55Kircher -
31Vider
Related MSK Work